Top Tweets for #LYMPRO
$TOMDF w/ approval of $BIIB and $ESALY drug Leqembi there will now be crucial need for non-invasive Alzheimer’s diagnostics. #LymPro is a blood test in development that detects Alzheimer’s early and also delivers quantitative data that is a 1:1 proxy for amyloid concentrations
$TOMDF Todos Medical to attend World Antiviral Congress 2022 from the 28th of November, 2022 – 1st of December, 2022 in Loews Coronado Bay Resort, San Diego.
Read the full press here https://t.co/tG7vsNNeRz
#Tollovid #Tollovir #Videssa #Lympro #COVID #LongCOVID #Antiviral
$TOMDF CEO @G_Commish will be making a corporate presentation and providing a corporate update to the investment community at BioFuture™ NYC 2022 on Tuesday November 8th, 2022 at 3:30 pm.
Read here https://t.co/89D1IZHJCF
#Tollovid #Tollovir #Videssa #Lympro #COVID #LongCOVID
$TOMDF Todos Medical provides corporate update for the year ahead to shareholders. They will present at the @EmergingGrowthC 10/12/22 at 2:00pm EST. https://t.co/bw46yEn0SY
Read here https://t.co/EuvU8gqUoM
#Tollovid #Tollovir #Videssa #Lympro #Alzhemiers #Provista #3CLPharma
$BIIB drug will need new diagnostics to segregate out responders given clinical and sub clinical risk of the 20% edema in treated and the lifelong nature of lecanemab use. $TOMDF diagnostic #LymPro immune-based AD Dx will help physicians sift through and make informed decisions.
$TOMDF Todos Medical Announces Positive #Alzheimers Biomarker Clinical Data from #LymPro vs. Amyloid PET Interim Analysis p=0.0000216 R =0.85
Part 2 data coming out Q4. Given #lecanemab likely on market 2023, early diagnosis now more important than ever.
https://t.co/CrgGJKuEqt
$TOMDF Todos Medical Announces Positive #Alzheimers Biomarker Clinical Data from #LymPro vs. Amyloid PET Interim Analysis p=0.0000216 R =0.85
Part 2 data coming out Q4. Given #lecanemab likely on market 2023, early diagnosis now more important than ever.
https://t.co/CrgGJKuEqt
#LymPro: Lymphocyte Proliferation Alzheimer’s blood diagnostic test. We have been saying AD is immune dysregulation for a long long long time. Confirmatory data coming soon for Part 2 of LymPro vs. Amyloid PET study. $TOMDF
$TOMDF Todos Medical Announces Saliva-Only #MonkeyPox Testing at CLIA/CAP Clinical Lab #Provista Diagnostics
#COVID #LongCOVID #Videssa #LymPro #MSPrecise #Tollovir #Tollovid #TolloTest
https://t.co/OaT7oEYpLE
If you missed $TOMDF Second Quarter 2022 Financial Results and Business Update Conference call yesterday, please click the link below to listen.
https://t.co/XtukUvo64n
#Tollovid #Tollovir #Videssa #longcovid #COVID #MonkeyPox #Lympro #Alzheimers
$TOMDF CEO @G_Commish presented at @EmergingGrowthC where he discussed the progress the company is making with #3CLPharma and gave an update on the diagnostic products. #LongCOVID #COVID #VIDESSA #BreastCancer #Alzheimer's #Tollovid #Tollovir #Lympro
https://t.co/EFsNS42JFd
$TOMDF CEO @G_Commish is presenting NOW at @theLDMicro, Wednesday, June 8 @ 1:30PM PT.
Register to watch at https://t.co/QZLbcslhow
#Tollovid #Tollovir #Videssa #Lympro #LongCovid
$TOMDF CEO @G_Commish is presenting at @theLDMicro TODAY, Wednesday, June 8 @ 1:30PM PT.
Register to watch at https://t.co/QZLbcslhow
#Tollovid #Tollovir #Videssa #Lympro #LongCovid
$TOMDF announced that President and CEO
@G_Commish will present at the @theLDMicro
Conference on June 8, 2022.
Read the full article here https://t.co/fgvM8KKdII
#Tollovid #Tollovir #Videssa #Lympro #Longcovid
$TOMDF Announces Enrollment Complete for Confirmatory Cohort of LymPro Alzheimer’s
Blood Test Clinical Validation Trial vs. Amyloid PET.
Read the full article here https://t.co/0YHqaIKZKQ
#Lympro #Alzheimers #clinicaltrial
$TOMDF releases a corporate update from CEO @G_Commish on the Company’s CLIA/CAP-certified lab #Provista Diagnostics, the Company’s #3CLPharma majority-owned subsidiary, #Videssa #Lympro #Tollovid #Tollovir #Tollotest, and stock exchange plans.
Read here https://t.co/SJC34jYcz4
@adamfeuerstein One thing that’s clear regardless of which shitty AD drugs get approved next is that screening patients before advancing to amyloid PET will remain critical due to costs and AD blood tests are the next needed advancement tools to improve screening for trials. #lympro data soon
@G_Commish $tomdf $ambs what will the upcoming #lympro studies do differently from past studies that gave such strong results? What's the margin of proof KOLS, medicare, or other reimbursing entities are looking for?
@G_Commish @BryConstantine @MarketRebels @jonnajarian @provistadx $TOMDF 32M MCAP ridiculous
1) Ph2 #Tollovir oral antiviral addresses key COVID mechanisms for prevention/early/mid/late disease
2) #TolloTest adjunct / displace antigen & complement PCR
3) #Videssa breast cancer test
4) #LymPro Alzheimer’s test
5) COVID test @provistadx
1/2
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers